Angiotensin (1-7)-expressing probiotic
Angiotensin (1-7)-expressing probiotic has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 9, 2023: “Multiomics profiling of the impact of an angiotensin (1-7)-expressing probiotic combined with exercise training in aged male rats”.
1 paper studies it2 findingsUpdated
- 1 lab in 1 country
- Funders: Eunice Kennedy Shriver National Institute of Child Health and Human Development and others
- Animals1
What did studies of Angiotensin (1-7)-expressing probiotic find?
2Studies of Angiotensin (1-7)-expressing probiotic measured 2 outcomes; the most studied are beta diversity (1 study) and gut microbial diversity (1).
Beta diversity
upin rats1
1 study
Beta diversity
upin rats1
Angiotensin (1-7)-expressing probiotic increases beta diversity in rats (F[2,56] = 2.66, P = 0.01).
“β-diversity (F[2,56] = 2.66; P = 0.01) among rats receiving our GMP.”
Animalsgenetically modified probiotic expressing Ang (1-7)12 wkmales
Journal of applied physiology (Bethesda, Md. : 1985)
Gut microbial diversity
upin rats1
1 study
Gut microbial diversity
upin rats1
Angiotensin (1-7)-expressing probiotic increases gut microbial diversity in rats (Inverse Simpson F[2,56] = 4.44, P = 0.02; Shannon-Wiener F[2,56] = 4.27, P = 0.02).
“The probiotic treatment enhanced α diversity (Inverse Simpson (F[2,56] = 4.44; P = 0.02); Shannon-Wiener (F[2,56] = 4.27; P = 0.02))”
Animalsgenetically modified probiotic expressing Ang (1-7)12 wkmales
Journal of applied physiology (Bethesda, Md. : 1985)